Smith & Nephew Plc - Company Profile
Powered by 
All the data and insights you need on Smith & Nephew Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Smith & Nephew Plc Strategy Report
- Understand Smith & Nephew Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Smith & Nephew Plc (Smith & Nephew) develops and markets medical devices with a focus on orthopedics and wound care. The company serves various professionals including surgeons, nurse specialists, payers and administrators, physicians and general practitioners among others.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Smith & Nephew's R&D activities focus on the development of innovative products to enhance its portfolio by using robotics and advanced technical software. In FY2023, the company launched 20 new products and completed development on two more for 2024. Its investment in robotics and AI continued with enhancements to the CORI Surgical System, including the CORI Digital Tensioner for knee replacement. The company also introduced personalized planning with AI and the RI.INSIGHTS data visualization platform on CORI. Additionally, it launched the AETOS Shoulder System and improved its negative pressure wound therapy system, RENASYS EDGE. The company’s cross-functional new product design and R&D aims to identify new products and potentially disruptive technologies and solutions. It observes and evaluates the external market trends and collates professional insights for the development of product strategies. The company spent US$339 million on its R&D activities in FY2023, which as a percentage of revenue, stood at 6.1%.
Business Segments
Overview
Provides exudate management and infection management products; topical biologics and skin substitutes that provide an approach to debridement, dermal repair and tissue regeneration; and negative pressure wound therapy (NPWT) and surgical debridement products for patients with chronic wounds related to the aged population such as leg ulcers and pressure sores. Major products include patient monitoring systems, traditional and single-use NPWT systems, and hydrosurgery systems. Major advanced wound bioactives include Collagenase Santyl ointment for chronic dermal ulcers and severe burns; Oasis wound matrix for the management of chronic and traumatic wounds and Regranex (becaplermin) gel 0.01% for the treatment of diabetic foot ulcers. Major advanced wound care products include antimicrobial barrier silver dressings, advanced foam wound dressings, iodine-based dressings, film and post-operative dressings, skincare products and gels.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides products for specialized knee replacement procedures; specialist products for the reconstruction of the hip joint; trauma products to stabilize severe fractures and deformity correction procedures; and robotics-assisted surgery, bone cement and accessories. Major knee implants include total knee systems, revision knee systems, and total knee arthroplasty system Major hip implants include Anthology hip system, Synergy hip system, total hip solution, Birmingham hip resurfacing (BHR) system, and Redapt revision hip system. Major other reconstruction products include Navio surgical system, bone cement and accessories. Key trauma products include Taylor Spatial Frame circular fixation system, plates, screws, plating systems, and soft tissue repair products.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides instruments, technologies and implants for surgeons to perform minimally invasive surgery of joints, including repair of soft tissue and degenerative conditions of knee, shoulder, hip and small joints. It also provides imaging solutions, energy-based and mechanical resection platforms, and fluid management and access portfolios; and ear, nose and throat (ENT) products. Major sports medicine joint repair products include Fast-Fix family of meniscal repair systems; Endobutton and Ultrabutton fixed and adjustable loop devices for knee ligament reconstruction; Biosure interference screws for ligament procedures; Healicoil suture anchor, Suturefix and Q-Fix all-suture anchors; FirstPass suture passer; and bioinductive implants. Major arthroscopic enabling technologies include Lens surgical imaging systems; Werewolf and Quantum 2 Coblation controllers; and Dyonics Shaver blades. Key ENT products include dissolvable and removable postoperative nasal dressings and epistaxis solutions.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Target Markets
Middle East, Africa, Russia, Latin America, and Asia (excluding Japan).
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Target Markets
The US, Australia, Europe, New Zealand, Canada and Japan.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward